Clinical Trial Update: Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion [Phase 4]

View source ↗

Summary

Phase 4 trial exploring EEG-based prediction for antidepressant response with duloxetine and bupropion was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Duloxetine (DULOXETINE)
• bupropion (bupropion)

Snippet

Sponsor: Alto Neuroscience | Conditions: Major Depressive Disorder | Phase 4 | Status: WITHDRAWN